Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network (CapACE)

December 11, 2018 updated by: Hyun-Soo Kim, Korean Association for the Study of Intestinal Diseases

Prospective Randomized Controlled Trial of Cap-Assisted ChromoEndoscopy(CapACE) Versus Conventional Colonoscopy(CC) for the Detection of Colorectal Neoplasia

The investigators plan to conduct a multi-center, randomized controlled trial to investigate the efficacy of cap-assisted chromoendoscopy as a screening test for detection of colorectal polyp. This study will be performed using web-based research network, e-VELOS in Korea.

Study Overview

Status

Completed

Conditions

Detailed Description

Various endoscopic tools have been tried to reduce polyp missing rate which has been reported to be 20-25%. Transparent cap-assisted colonoscopy has been suggested to improve visualization of the lesion that are difficult to access, such as tangentially located lesions and those located within a limited luminal space. Chromoendoscopy with indigocarmine spraying was reported to increases the detection rates of polyp, especially in right colon and rectum. However, there also have been mixed results regarding polyp detection rates of the endoscopic methods. Moreover, there is no data regarding the impact of the screening tools on longterm recurrence rate of colorectal polyp. Therefore, in this study, we intend to perform a multi-center, randomized controlled trial to investigate the efficacy of cap-assisted chromoendoscopy as a screening test for detection of colorectal polyps. This study will be performed using web-based research network, e-VELOS in Korea.

Study Type

Interventional

Enrollment (Actual)

1905

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Anyang, Korea, Republic of
        • Hallym University Medical Center
      • Busan, Korea, Republic of
        • Kosin University College of Medicine
      • Cheonan, Korea, Republic of
        • Dankuk University college of medicine hospital
      • Goyang, Korea, Republic of
        • National Cancer Center Hospital, National Cancer Center
      • Guri-si, Korea, Republic of
        • Hanyang University Guri Hospital, Hanyang University College of Medicine
      • Incheon, Korea, Republic of
        • Catholic university St. Mari's hospital
      • Seoul, Korea, Republic of
        • Samsung Medical Center, Sungkyunkwan University School of Medicine
      • Seoul, Korea, Republic of
        • Yonsei University College of Medicine
      • Seoul, Korea, Republic of
        • Asan Medical Center, University of Ulsan College of Medicine
      • Seoul, Korea, Republic of
        • Ewha Mokdong hospital
      • Seoul, Korea, Republic of
        • Kyung Hee University Hospital at Gang Dong, Kyung Hee University School of Medicine
      • Seoul, Korea, Republic of
        • Sunchunhyang University hospital
      • Seoul, Korea, Republic of
        • Sungkyunkwan University Kangbuk Samsung Hospital
      • Wonju, Korea, Republic of
        • Yonsei Uiniversity Wonju College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All asymptomatic colonoscopic examinees

Exclusion Criteria:

  • Familial history of hereditary colorectal cancer
  • History of colorectal cancer
  • Patients had received colonoscopy examination before
  • Familial or past history of FAP(familiar adenomatous polyposis)
  • Colonic polyposis syndrome
  • Prior colonic resection of any part of the colon
  • Allergy to indigo carmine
  • Inflammatory bowel disease
  • Pregnancy
  • Inability to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cap-assisted chromoendoscopy
To the tip of the colonoscope, transparent cap is fitted and applied. In addition, panchromoendoscopy using indigocarmine solution is preformed in this group.
A cap (irrigation cap) is a simple plastic device that can be attached to the tip of a colonoscope before performing the colonoscopy. For chromoendoscopy, 0.09% indigocarmine was administered via irrigation cap .
No Intervention: Standard colonoscopy
Neither transparent cap nor chromoendoscopy is applied in this group and standard colonoscopy is performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
The proportion of subjects with at least one adenoma
7 days is needed to confirm the pathologic examination.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proximal adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
Proportion of subjects with at least one proximal colon adenoma
7 days is needed to confirm the pathologic examination.
Proximal serrated polyp detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
Proportion of subjects with at least one proximal serrated polyp/adenoma
7 days is needed to confirm the pathologic examination.
Advanced adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
Proportion of subjects with at least one advanced adenoma
7 days is needed to confirm the pathologic examination.
Serrated adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
Proportion of subjects with at least one serrated adenoma
7 days is needed to confirm the pathologic examination.
Cancer detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
Proportion of subjects with at least one cancer
7 days is needed to confirm the pathologic examination.
Surveillance
Time Frame: 7 - 14 days
Surveillance interval recommendations for both groups were classified based on adenoma detection
7 - 14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hyun Soo Kim, Korean Association for the Study of Intestinal Diseases

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2010

Primary Completion (Actual)

March 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

April 26, 2010

First Submitted That Met QC Criteria

April 27, 2010

First Posted (Estimate)

April 28, 2010

Study Record Updates

Last Update Posted (Actual)

December 13, 2018

Last Update Submitted That Met QC Criteria

December 11, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Neoplasm

Clinical Trials on cap-assisted chromoendoscopy

3
Subscribe